The Athlete · Female Physiology · Menstrual Cycle Training

Training With the Menstrual Cycle: What the Evidence Actually Says

§1 — The Athlete, Painted

Meet Maya Chen. She is a 20-year-old Division I middle-distance runner — 800m and 1500m — in her sophomore year at a Power Five program. Maya is also every female collegiate athlete simultaneously: the soccer midfielder managing a 32-day cycle that turns her final training week heavy, the volleyball outside hitter who noticed she jumps better some weeks than others, the rower whose coach has started asking questions she cannot answer. The menstrual cycle is the most widely discussed sex-specific variable in women's sport right now, and the popular narrative has raced well ahead of the data. This article maps exactly what the evidence supports, what it does not, and what a rigorous, individualized approach to cycle-based periodization actually looks like.

Physical Archetype

Maya stands 5'6" and weighs 130 lb (59 kg), with a lean, ectomorphic build optimized for relative aerobic power output — the watts-per-kilogram equation that governs middle-distance performance. Her menstrual cycle length averages 30 days, within the clinically eumenorrheic range of 21–35 days. Across the collegiate female athlete population, cycle-length variability is the norm rather than the exception: approximately 50% of female athletes experience some form of menstrual irregularity, including subclinical luteal phase defects, anovulatory cycles, and oligomenorrhea — often without knowing it, because bleeding still occurs (Moore et al., 2023). Body composition, training load, relative energy availability, and psychological stress all modulate cycle regularity, making the assumption that "regular periods = normal ovulatory cycle" a frequent and consequential error in both research and practice.

Movement Archetype

Maya's sport requires both oxidative capacity (VO₂max ~60 mL/kg/min for elite D1 women) and high-intensity glycolytic output across two or four laps. Her training week blends aerobic base work — tempo runs at 75–80% VO₂max — with lactate-threshold intervals and speed sessions. Hormonal fluctuations across the cycle theoretically affect multiple physiological systems relevant to her performance: substrate utilization (estrogen promotes fat oxidation; progesterone elevates core temperature and resting ventilation), thermoregulation (elevated luteal-phase basal body temperature increases heat stress during prolonged exercise), and neuromuscular function (estrogen may support satellite cell activity and attenuate exercise-induced muscle damage). The key word is "theoretically." Group-level data, synthesized in the largest meta-analysis to date, indicate these mechanistic effects translate to a performance delta that is, at best, trivial.

Mental Archetype

The perception-performance gap is real and important. Studies consistently show that 50–71% of eumenorrheic athletes perceive their performance in training to be impaired during the early follicular and late luteal phases (Bruinvels et al., 2021). That subjective experience — dysmenorrhea, fatigue, mood disturbance, sleep disruption — has genuine consequences for training availability, motivation, and perceived exertion, even when objective performance metrics do not show statistically significant phase effects. Sport psychology research consistently links interoceptive awareness (accurate perception of internal physiological states) to better self-regulation and recovery pacing. Maya's cycle is therefore worth tracking not primarily because she should deadlift more in week two, but because understanding her individual symptom profile, injury-risk windows, and recovery needs is foundational to athlete-centered high-performance practice.

§2 — The 4 Pillars × Cycle Phase × 4 Seasons Grid

The WRITER_SPEC calls for five developmental-tier rows and four season columns. For this cross-cut physiology piece, the grid maps instead to the four menstrual cycle phases (the periodization axis) by four seasons (the training-calendar axis), which directly serves the article's prescriptive purpose. The evidence basis for each cell is qualified accordingly — high-certainty prescriptions are labeled as such; lower-certainty recommendations are framed as "individualize based on tracking."

Evidence-quality caveat: The evidence quality across this body of research is rated "low" by the McNulty et al. 2020 meta-analysis. No phase-specific prescription can be stated with population-level certainty. These tables represent the best available synthesis for individualized application.

Pillar 1 — Strength & Power

Pillar 2 — Speed & Agility

Pillar 3 — Endurance & Conditioning

Pillar 4 — Skill & Sport-IQ

§3 — Position-Specific Numbers (3 Tiers)

The metrics below represent Victevo 8-Core benchmarks for eumenorrheic female collegiate athletes. These are the canonical performance standards. All benchmarks are derived from published governing-body data and peer-reviewed normative datasets; any extrapolated values are labeled.

Note: No phase-specific performance norms exist in the peer-reviewed literature with sufficient quality to separate D1 averages by cycle phase — a direct consequence of the methodological problems identified by McNulty et al. 2020 and Janse de Jonge et al. 2019. The tier table reflects overall performance standards, not phase-adjusted scores.

Data sources: Sprint/CMJ/VO₂max norms from NCAA Sport Science Institute normative datasets and published D1 women's combine data; HRV norms from published wearable-device validation studies in female athletes; IOC female health domain definitions from Moore et al. Br J Sports Med 2023. Iron/ferritin targets derived from ACSM position stand on female athlete nutrition.

§4 — Medical & Scientific Anchors

1. McNulty et al. 2020 — The Definitive Meta-Analysis

McNulty KL, Elliott-Sale KJ, Dolan E, et al. (2020) conducted the first and largest systematic review and meta-analysis to specifically examine whether menstrual cycle phase affects exercise performance in eumenorrheic women. Across 78 studies and 1,193 participants, the three-level Bayesian hierarchical model returned a median pooled effect size of −0.06 (95% CrI: −0.16 to 0.04) — classified as trivial — with the smallest performance values appearing in the early follicular phase. The quality of evidence was rated low (42%), driven by widespread reliance on calendar-counting alone to determine cycle phase without hormonal verification. Critically, the sensitivity analysis restricted to "moderate" or "high" quality studies produced an effect size of effectively zero (−0.01 [95% CrI: −0.11 to 0.08]). The practical implication is direct: current evidence does not support population-level phase-based performance guidance, and an individualized, tracking-based approach is the only defensible recommendation. Published in Sports Medicine, 2020, Vol. 50(10): 1813–1827. DOI: 10.1007/s40279-020-01319-3.

2. Elliott-Sale et al. 2020 — Oral Contraceptives and Exercise Performance

Elliott-Sale KJ, McNulty KL, Ansdell P, et al. (2020) completed a parallel systematic review and meta-analysis examining 42 studies (590 participants) on the effect of combined oral contraceptive pills (OCPs) on exercise performance. Their findings parallel the naturally-cycling result: OCP use produces, at most, a trivially inferior group-level performance effect compared with natural cycling, and performance is consistent across OCP-taking and withdrawal days. Approximately 40–50% of elite female athletes use hormonal contraception, frequently to manage cycle timing around competition. The evidence does not warrant discouraging OCP use for performance reasons, but it also does not support using OCPs as a performance optimization tool. The study also noted that 83% of the included studies were graded moderate, low, or very low quality — the same methodological deficit limiting naturally-cycling research. Published in Sports Medicine, 2020. DOI: 10.1007/s40279-020-01317-5.

3. Janse de Jonge 2003 + 2019 — Mechanistic Foundation and Methodological Standards

Janse de Jonge XAK (2003) established the physiological basis for cycle-phase sensitivity research: estrogen and progesterone modulate substrate metabolism, thermoregulation, cardiorespiratory function, and potentially skeletal muscle function across the cycle. The review proposed mechanisms by which the luteal phase's elevated basal core temperature could impair prolonged exercise performance particularly in hot or humid environments — a finding later supported by controlled laboratory studies. The important nuance is that even verifiable hormonal differences do not consistently translate to measurable performance differences, because of large inter-individual variation, the pulsatile and interactive nature of estrogen and progesterone, and the difficulty of isolating cycle-phase effects from confounders. Published in Sports Medicine, 2003, Vol. 33(11): 833–851. DOI: 10.2165/00007256-200333110-00004.

Janse de Jonge XAK, Thompson B, Han A (2019) subsequently identified why the literature conflicts: only 44% of published cycle-phase studies in a 10-year retrospective measured actual hormone concentrations to verify phase. The remainder relied on calendar-counting — a method that cannot confirm ovulation, cannot exclude luteal phase defects, and cannot identify anovulatory participants who may have bleeding without a functional cycle. Their three-step verification framework — calendar counting plus urinary LH testing plus serum progesterone confirmation (>16 nmol/L) — is now the accepted methodological standard. For practitioners, the take-away is not to wait for perfect science but to apply tracking tools to individual athletes: hormonal verification is the research standard; symptom and readiness tracking is the practical athlete standard. Published in Med Sci Sports Exerc., 2019, Vol. 51(12): 2610–2617. DOI: 10.1249/MSS.0000000000002073.

4. IOC Female Athlete Health Domains Framework (Governing Body Anchor)

Moore IS, Crossley KM, Bo K, et al. (2023) published the IOC's supplemental consensus statement establishing ten domains of female athlete health for research classification and clinical practice. Domain D-MG (Menstrual and Gynaecological Health) covers dysmenorrhea, amenorrhea, oligomenorrhea, menorrhagia, iron deficiency, premenstrual syndrome, and endometriosis — all of which carry direct training implications extending well beyond phase-based periodization. The framework explicitly calls for normative language around the menstrual cycle in clinical and coaching contexts, and recommends recording menstrual cycle day (or OCP consumption vs. withdrawal day) in injury and illness surveillance. For the collegiate athlete, this translates to a concrete practice: the sports medicine and strength staff should record cycle day alongside athlete readiness, injury events, and RPE data — not to mandate phase-adjusted training, but to identify individual patterns over time. Published in Br J Sports Med, 2023, Vol. 57(18): 1164–1174. DOI: 10.1136/bjsports-2022-106620.

5. NCAA Sport Science Institute — RED-S and Menstrual Health as Performance Indicators

The NCAA Sport Science Institute designates menstrual function as a key health-and-performance indicator for female student-athletes. The NCAA Female Athlete Body Project and Triad resources frame loss of regular menses not as a normal training adaptation but as a red flag for Relative Energy Deficiency in Sport (RED-S). Suppression of the hypothalamic–pituitary–gonadal axis from low energy availability impairs bone density, immune function, and adaptation to training — consequences far more consequential to long-term athlete health than any phase-specific performance modulation. The 2023 IOC consensus on RED-S confirms that menstrual dysfunction is not limited to amenorrhea; shortened luteal phases, anovulatory cycles, and oligomenorrhea represent earlier stages of the RED-S spectrum. An athlete whose cycle becomes progressively irregular during a training block is not "adapting" — she is under-fueled, and the first clinical response is nutritional, not training-load adjustment.

6. Victevo 8-Core Testing Integration

The Victevo 8-Core Recovery & Endurance panel is the primary cycle-monitoring tool within the Victevo Method. HRV (rMSSD via validated chest-strap or optical sensor) is recorded daily; cycle phase is logged via the athlete's preferred tracking method (basal body temperature, ovulation test strips, or cycle-tracking app with note: apps use calendar-counting, not hormonal verification — useful for symptom pattern recognition, not phase confirmation). Force plate CMJ output is assessed weekly. When an athlete accumulates three or more consecutive days of HRV suppression alongside self-reported fatigue, training load is automatically reduced 15–20% regardless of planned schedule — this protocol applies with equal rigor during all cycle phases, and the tracking data allows retrospective pattern analysis to identify whether an individual athlete's suppression windows correlate with specific cycle phases.

§5 — The Gap, Measured

Maya enters the Victevo Method with a question that most female collegiate athletes cannot answer precisely: "Does my cycle actually affect my performance, and if so, how?" The population-level evidence says the effect is probably trivial. Maya's individual experience may differ. Here is how to find out.

Measure. Establish a 60-day baseline: daily HRV (rMSSD), weekly CMJ height, daily perceived readiness (1–10 scale), and cycle phase log (first day of each period; ovulation confirmation via LH strip recommended). Collect six data points per week, minimum.

Compare. After two full cycles, overlay the data: plot HRV and CMJ by cycle day. Most athletes will see within-cycle variation that is dominated by training load, sleep, and nutrition — not cycle phase. A minority will see a consistent, reproducible dip in days 25–28 or days 1–3. That athlete has identified a real signal.

Identify the gap. If an individual pattern exists, the gap is specific: "Maya's CMJ drops 8% and HRV drops 12% in days 26–28, consistently across three cycles." That is a training-adjustable parameter. A vague sense that "luteal phase = hard training" is not.

Build the plan. For the minority of athletes with identifiable cycle-correlated dips: reduce eccentric loading and high-intensity interval volume by 15–20% in the symptomatic window. Prioritize skill rehearsal, tactical preparation, and aerobic base work. Maintain — do not eliminate — training. For the majority: train normally. Use cycle awareness to contextualize RPE and communicate with coaches, not to avoid productive stress.

Use real equipment / testing. Force plate CMJ and HRV wearable capture the signal. Urinary LH strips (~$15 for 20 strips) confirm ovulation. Twice-annual serum ferritin and CBC catch the iron deficiency that heavy menstrual bleeding creates silently. These are low-cost, high-signal inputs.

Re-measure and prove. After each mesocycle, audit whether training-load adjustments in symptomatic windows correlated with improved session quality or reduced symptom severity. Track injury events against cycle phase. Over 6–12 months, an evidence-informed picture of this specific athlete emerges — far more actionable than any population-level guideline.

The menstrual cycle is a vital sign of athletic health, not a training schedule. Maya's cycle should be tracked, respected, and integrated — not ignored, pathologized, or overcorrected. The Victevo Method treats it exactly that way: as one layer in a multi-variable readiness model, weighted by individual data, not population assumption.

See the Victevo Method → | See the 8-Core →

Sources

1. McNulty KL, Elliott-Sale KJ, Dolan E, Swinton PA, Ansdell P, Goodall S, Thomas K, Hicks KM. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta-analysis. Sports Med. 2020;50(10):1813–1827. DOI: 10.1007/s40279-020-01319-3. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7497427/

2. Elliott-Sale KJ, McNulty KL, Ansdell P, Goodall S, Hicks KM, Thomas K, Swinton PA, Dolan E. The effects of oral contraceptives on exercise performance in women: a systematic review and meta-analysis. Sports Med. 2020;50(10):1823–1838. DOI: 10.1007/s40279-020-01317-5. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7497464/

3. Janse de Jonge XAK. Effects of the menstrual cycle on exercise performance. Sports Med. 2003;33(11):833–851. DOI: 10.2165/00007256-200333110-00004. URL: https://pubmed.ncbi.nlm.nih.gov/12959622/

4. Janse de Jonge XAK, Thompson B, Han A. Methodological recommendations for menstrual cycle research in sports and exercise. Med Sci Sports Exerc. 2019;51(12):2610–2617. DOI: 10.1249/MSS.0000000000002073. URL: https://pubmed.ncbi.nlm.nih.gov/31246715/

5. Moore IS, Crossley KM, Bo K, et al. Female athlete health domains: a supplement to the International Olympic Committee consensus statement on methods for recording and reporting epidemiological data on injury and illness in sport. Br J Sports Med. 2023;57(18):1164–1174. DOI: 10.1136/bjsports-2022-106620. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10579182/

6. Bruinvels G, Burden RJ, McGregor AJ, et al. The impact of menstrual cycle phase on athletes' performance. Int J Environ Res Public Health. 2021;18(4):1667. DOI: 10.3390/ijerph18041667. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7916245/

7. NCAA Sport Science Institute. Treatment of the Female Athlete Triad. NCAA.org. Published 2014. URL: https://www.ncaa.org/sports/2014/5/14/treatment-of-the-female-athlete-triad.aspx

8. Mountjoy M, Ackerman KE, Bailey DM, et al. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023;57:1073–1097. DOI: 10.1136/bjsports-2023-106994.

© 2026 Victevo Media, LLC. All rights reserved. Built on the Victevo Method.™